This is a $12,500.00 firm fixed price purchase order awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company. The contract is for the acquisition of a license and warranty for the GridION device to perform whole genome sequencing (WGS) at the CDC/DGHP laboratory on behalf of the CDC in Thailand. The contract has no set-aside designation. Oxford Nanopore Technologies Inc. is a proven provider of next-generation sequencing equipment, consumables, and services to federal agencies including the National Institutes of Health, CDC, Department of Agriculture, and Department of Defense. The company holds multiple indefinite delivery/indefinite quantity (IDIQ) vehicles that facilitate efficient ordering of its products to support various genomics research initiatives across the government.
Generated 5/19/24, 1:10 AM